Praxis Precision Medicines PRAX
NASDAQ PRAX
$263.43 -1.05 (-0.40%)
As of: Oct 21, 2026 · 11:18 AM EDT

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)

Updated

Praxis Precision Medicines (PRAX) recorded Revenue of $7.46 million in Q4 2024, compared with $515,000 a year earlier.

Analysis

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024) Analysis & Trends

For FY2024, Praxis Precision Medicines reported Revenue of $8.55 million, up 249.5% from FY2023.

  • Across earlier years, Revenue came in at $2.45 million in FY2023.
  • The Q4 2024 figure is the highest quarterly Revenue in data going back to Q1 2023.
  • Per Business Quant, the preceding three quarters came in at $302,000 (Q3 2024), $357,000 (Q2 2024) and $431,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn 16.99 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 15.03 Bn
10 Praxis Precision Medicines 7.69 Bn 5.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.46 Mn
Sep 30, 2024 302,000.00
Jun 30, 2024 357,000.00
Mar 31, 2024 431,000.00
Dec 31, 2023 515,000.00
Sep 30, 2023 468,000.00
Jun 30, 2023 781,000.00
Mar 31, 2023 683,000.00
API Access

Praxis Precision Medicines Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PRAX&period=max&api_key=YOUR_API_KEY